205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
6.79%
Revenue growth under 50% of AMD's 15.82%. Michael Burry would suspect a deteriorating sales pipeline or weaker brand.
7.87%
Gross profit growth under 50% of AMD's 17.97%. Michael Burry would be concerned about a severe competitive disadvantage.
20.72%
EBIT growth 50-75% of AMD's 34.71%. Martin Whitman would suspect suboptimal resource allocation.
12.68%
Operating income growth under 50% of AMD's 26.95%. Michael Burry would be concerned about deeper cost or sales issues.
24.76%
Net income growth under 50% of AMD's 356.67%. Michael Burry would suspect the firm is falling well behind a key competitor.
24.49%
EPS growth under 50% of AMD's 348.48%. Michael Burry would suspect deeper structural issues or share dilution limiting per-share gains.
24.14%
Diluted EPS growth under 50% of AMD's 353.12%. Michael Burry would worry about an eroding competitive position or excessive dilution.
0.22%
Share reduction more than 1.5x AMD's 1.33%. David Dodd would see if the company is taking advantage of undervaluation to retire shares.
0.32%
Diluted share reduction more than 1.5x AMD's 0.91%. David Dodd would validate if the company is aggressively retiring shares or limiting option exercises.
13.33%
Dividend growth of 13.33% while AMD is flat. Bruce Berkowitz would see if this can become a bigger advantage long term.
47.26%
OCF growth at 50-75% of AMD's 63.42%. Martin Whitman would question if the firm lags in monetizing sales effectively.
47.49%
FCF growth 50-75% of AMD's 81.13%. Martin Whitman would see if structural disadvantages exist in generating free cash.
47.46%
10Y revenue/share CAGR above 1.5x AMD's 15.34%. David Dodd would confirm if management’s strategic vision consistently outperforms the competitor.
40.65%
5Y revenue/share CAGR under 50% of AMD's 118.11%. Michael Burry would suspect a significant competitive gap or product weakness.
16.50%
3Y revenue/share CAGR under 50% of AMD's 90.23%. Michael Burry might see a serious short-term decline in relevance vs. the competitor.
120.33%
10Y OCF/share CAGR under 50% of AMD's 252.49%. Michael Burry would worry about a persistent underperformance in cash creation.
63.52%
Below 50% of AMD's 573.27%. Michael Burry would be alarmed about sustained underperformance in generating free operational cash.
18.07%
3Y OCF/share CAGR 1.25-1.5x AMD's 13.66%. Bruce Berkowitz might see if strategic cost controls or product mix drove recent gains.
128.52%
Net income/share CAGR at 50-75% of AMD's 178.45%. Martin Whitman might question if the firm’s product or cost base lags behind.
122.19%
Below 50% of AMD's 1224.66%. Michael Burry would worry about a substantial lag vs. the competitor’s profit ramp-up.
425.94%
Below 50% of AMD's 2194.25%. Michael Burry suspects a steep short-term disadvantage in bottom-line expansion.
12.26%
Below 50% of AMD's 237.82%. Michael Burry would suspect poor capital allocation or persistent net losses eroding long-term equity build-up.
1.64%
Below 50% of AMD's 1012.53%. Michael Burry sees a substantially weaker mid-term book value expansion strategy in place.
-4.74%
Negative 3Y equity/share growth while AMD is at 650.68%. Joel Greenblatt demands an urgent fix in capital structure or profitability vs. the competitor.
681.02%
Dividend/share CAGR of 681.02% while AMD is zero. Bruce Berkowitz sees a slight advantage in stepping up payouts steadily.
167.12%
Dividend/share CAGR of 167.12% while AMD is zero. Bruce Berkowitz sees a minor advantage in stepping up distributions, even modestly.
64.37%
3Y dividend/share CAGR of 64.37% while AMD is zero. Bruce Berkowitz sees a minor positive difference that could attract dividend-focused investors.
1.58%
Our AR growth while AMD is cutting. John Neff questions if the competitor outperforms in collections or if we’re pushing credit to maintain sales.
-5.65%
Inventory is declining while AMD stands at 8.28%. Joel Greenblatt sees potential cost and margin benefits if sales hold up.
6.28%
Asset growth well under 50% of AMD's 27.61%. Michael Burry sees the competitor as far more aggressive in building resources or capacity.
10.11%
Under 50% of AMD's 48.96%. Michael Burry raises concerns about the firm’s ability to build intrinsic value relative to its rival.
4.74%
We have some new debt while AMD reduces theirs. John Neff sees the competitor as more cautious unless our expansions pay off strongly.
0.52%
R&D dropping or stable vs. AMD's 12.80%. David Dodd sees near-term margin benefits if the product pipeline is already strong.
-2.21%
We cut SG&A while AMD invests at 12.82%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.